Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edap Tms (EDAP) Cash & Equivalents (2016 - 2025)

Edap Tms' Cash & Equivalents history spans 16 years, with the latest figure at $20.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 35.85% year-over-year to $20.5 million; the TTM value through Dec 2025 reached $20.5 million, down 35.85%, while the annual FY2025 figure was $20.5 million, 34.02% down from the prior year.
  • Cash & Equivalents reached $20.5 million in Q4 2025 per EDAP's latest filing, down from $31.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $64.4 million in Q4 2022 to a low of $20.5 million in Q4 2025.
  • Average Cash & Equivalents over 5 years is $43.5 million, with a median of $46.8 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: soared 83.31% in 2021, then crashed 35.85% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $54.0 million in 2021, then rose by 19.34% to $64.4 million in 2022, then fell by 27.39% to $46.8 million in 2023, then crashed by 31.83% to $31.9 million in 2024, then crashed by 35.85% to $20.5 million in 2025.
  • Per Business Quant, the three most recent readings for EDAP's Cash & Equivalents are $20.5 million (Q4 2025), $31.9 million (Q4 2024), and $46.8 million (Q4 2023).